Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0V5LG
|
|||
| Former ID |
DNCL003189
|
|||
| Drug Name |
ChronVac-C hepatitis C DNA vaccine
|
|||
| Synonyms |
ChronVac-C (TN)
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Hepatitis C virus infection [ICD-11: 1E51.1; ICD-10: B18.2] | Phase 1/2 | [1] | |
| Company |
Inovio Pharmaceuticals; ChronTech Pharma
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Hepatitis C virus Deoxyribonucleic acid (HCV DNA) | Target Info | . | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00563173) Phase I/IIa Dose Ranging CHRONVAC-C Study in Chronic HCV Patients. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Inovio Pharmaceuticals. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.